Sanyal and colleagues reported a phase 2a, randomized, placebo-controlled trial in adults with metabolic dysfunction-associated steatotic liver disease in Nature Medicine in 2024
This is all reassuring news for those who have dealt with stubborn weight changes during midlife and want or need support beyond lifestyle strategies
Are there specific foods to avoid
Research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, originally developed to manage type 2 diabetes, may be able to treat a wide range of conditions involving impulse control, like binge eating disorder
doi: 10.1097/ico.0000000000000408 295 Jones-JordanLAWallineJJSinnottLTKymesSMZadnikK
HNF4A regulates the formation of hepatic progenitor cells from human iPSC-derived endoderm by facilitating efficient recruitment of RNA pol II